Hygeia Healthcare Holdings Co., Limited (6078.HK)

HKD 14.76

(-2.25%)

Market Cap (In HKD)

9.23 Billion

Revenue (In HKD)

4.07 Billion

Net Income (In HKD)

682.92 Million

Avg. Volume

4.48 Million

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
14.6-39.2
PE
-
EPS
-
Beta Value
0.365
ISIN
KYG4712E1035
CUSIP
G4712E103
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Mr. Yiwen Zhu
Employee Count
-
Website
https://www.hygeia-group.com.cn
Ipo Date
2020-06-29
Details
Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals that offer oncology healthcare services, such as tumor screening and genetic diagnosis, radiotherapy, surgery, chemotherapy, immunotherapy, targeted therapy, oncology rehabilitation, nutrition, and hospice care. It also provides radiotherapy center consulting services; and licenses its SRT equipment, as well as offers maintenance and technical support services for its SRT equipment. In addition, the company provides hospital and corporate management, and supply chain services. As of December 31, 2021, it operated or managed a network of 12 oncology-focused hospitals in 9 cities in 7 Provinces in the People's Republic of China. Hygeia Healthcare Holdings Co., Limited was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.